hepatitis B cores (Medeva)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Namehepatitis B cores (Medeva)
Drug Alias NameHepacore
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionImmunostimulants
TargetsUpdating
Therapy Area/IndicationsHepatitis B
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUcb Celltech
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUcb Celltech
Active IndicationsN/A
Inactive IndicationsHepatitis B

Other Information

ATC CodeN/A
Related LinksN/A